Cargando…

Extended-synaptotagmin 1 engages in unconventional protein secretion mediated via SEC22B(+) vesicle pathway in liver cancer

Protein secretion in cancer cells defines tumor survival and progression by orchestrating the microenvironment. Studies suggest the occurrence of active secretion of cytosolic proteins in liver cancer and their involvement in tumorigenesis. Here, we investigated the identification of extended-synapt...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Kohji, Motohashi, Saya, Oikawa, Tsunekazu, Tago, Naoko, Koizumi, Rei, Ono, Masaya, Tachibana, Toshiaki, Yoshida, Ayano, Yoshida, Saishu, Shimoda, Masayuki, Oka, Masahiro, Yoneda, Yoshihiro, Yoshida, Kiyotsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457520/
https://www.ncbi.nlm.nih.gov/pubmed/36044553
http://dx.doi.org/10.1073/pnas.2202730119
_version_ 1784786075571453952
author Yamada, Kohji
Motohashi, Saya
Oikawa, Tsunekazu
Tago, Naoko
Koizumi, Rei
Ono, Masaya
Tachibana, Toshiaki
Yoshida, Ayano
Yoshida, Saishu
Shimoda, Masayuki
Oka, Masahiro
Yoneda, Yoshihiro
Yoshida, Kiyotsugu
author_facet Yamada, Kohji
Motohashi, Saya
Oikawa, Tsunekazu
Tago, Naoko
Koizumi, Rei
Ono, Masaya
Tachibana, Toshiaki
Yoshida, Ayano
Yoshida, Saishu
Shimoda, Masayuki
Oka, Masahiro
Yoneda, Yoshihiro
Yoshida, Kiyotsugu
author_sort Yamada, Kohji
collection PubMed
description Protein secretion in cancer cells defines tumor survival and progression by orchestrating the microenvironment. Studies suggest the occurrence of active secretion of cytosolic proteins in liver cancer and their involvement in tumorigenesis. Here, we investigated the identification of extended-synaptotagmin 1 (E-Syt1), an endoplasmic reticulum (ER)-bound protein, as a key mediator for cytosolic protein secretion at the ER–plasma membrane (PM) contact sites. Cytosolic proteins interacted with E-Syt1 on the ER, and then localized spatially inside SEC22B(+) vesicles of liver cancer cells. Consequently, SEC22B on the vesicle tethered to the PM via Q-SNAREs (SNAP23, SNX3, and SNX4) for their secretion. Furthermore, inhibiting the interaction of protein kinase Cδ (PKCδ), a liver cancer-specific secretory cytosolic protein, with E-Syt1 by a PKCδ antibody, decreased in both PKCδ secretion and tumorigenicity. Results reveal the role of ER–PM contact sites in cytosolic protein secretion and provide a basis for ER-targeting therapy for liver cancer.
format Online
Article
Text
id pubmed-9457520
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher National Academy of Sciences
record_format MEDLINE/PubMed
spelling pubmed-94575202023-03-03 Extended-synaptotagmin 1 engages in unconventional protein secretion mediated via SEC22B(+) vesicle pathway in liver cancer Yamada, Kohji Motohashi, Saya Oikawa, Tsunekazu Tago, Naoko Koizumi, Rei Ono, Masaya Tachibana, Toshiaki Yoshida, Ayano Yoshida, Saishu Shimoda, Masayuki Oka, Masahiro Yoneda, Yoshihiro Yoshida, Kiyotsugu Proc Natl Acad Sci U S A Biological Sciences Protein secretion in cancer cells defines tumor survival and progression by orchestrating the microenvironment. Studies suggest the occurrence of active secretion of cytosolic proteins in liver cancer and their involvement in tumorigenesis. Here, we investigated the identification of extended-synaptotagmin 1 (E-Syt1), an endoplasmic reticulum (ER)-bound protein, as a key mediator for cytosolic protein secretion at the ER–plasma membrane (PM) contact sites. Cytosolic proteins interacted with E-Syt1 on the ER, and then localized spatially inside SEC22B(+) vesicles of liver cancer cells. Consequently, SEC22B on the vesicle tethered to the PM via Q-SNAREs (SNAP23, SNX3, and SNX4) for their secretion. Furthermore, inhibiting the interaction of protein kinase Cδ (PKCδ), a liver cancer-specific secretory cytosolic protein, with E-Syt1 by a PKCδ antibody, decreased in both PKCδ secretion and tumorigenicity. Results reveal the role of ER–PM contact sites in cytosolic protein secretion and provide a basis for ER-targeting therapy for liver cancer. National Academy of Sciences 2022-08-31 2022-09-06 /pmc/articles/PMC9457520/ /pubmed/36044553 http://dx.doi.org/10.1073/pnas.2202730119 Text en Copyright © 2022 the Author(s). Published by PNAS. https://creativecommons.org/licenses/by-nc-nd/4.0/This article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Biological Sciences
Yamada, Kohji
Motohashi, Saya
Oikawa, Tsunekazu
Tago, Naoko
Koizumi, Rei
Ono, Masaya
Tachibana, Toshiaki
Yoshida, Ayano
Yoshida, Saishu
Shimoda, Masayuki
Oka, Masahiro
Yoneda, Yoshihiro
Yoshida, Kiyotsugu
Extended-synaptotagmin 1 engages in unconventional protein secretion mediated via SEC22B(+) vesicle pathway in liver cancer
title Extended-synaptotagmin 1 engages in unconventional protein secretion mediated via SEC22B(+) vesicle pathway in liver cancer
title_full Extended-synaptotagmin 1 engages in unconventional protein secretion mediated via SEC22B(+) vesicle pathway in liver cancer
title_fullStr Extended-synaptotagmin 1 engages in unconventional protein secretion mediated via SEC22B(+) vesicle pathway in liver cancer
title_full_unstemmed Extended-synaptotagmin 1 engages in unconventional protein secretion mediated via SEC22B(+) vesicle pathway in liver cancer
title_short Extended-synaptotagmin 1 engages in unconventional protein secretion mediated via SEC22B(+) vesicle pathway in liver cancer
title_sort extended-synaptotagmin 1 engages in unconventional protein secretion mediated via sec22b(+) vesicle pathway in liver cancer
topic Biological Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457520/
https://www.ncbi.nlm.nih.gov/pubmed/36044553
http://dx.doi.org/10.1073/pnas.2202730119
work_keys_str_mv AT yamadakohji extendedsynaptotagmin1engagesinunconventionalproteinsecretionmediatedviasec22bvesiclepathwayinlivercancer
AT motohashisaya extendedsynaptotagmin1engagesinunconventionalproteinsecretionmediatedviasec22bvesiclepathwayinlivercancer
AT oikawatsunekazu extendedsynaptotagmin1engagesinunconventionalproteinsecretionmediatedviasec22bvesiclepathwayinlivercancer
AT tagonaoko extendedsynaptotagmin1engagesinunconventionalproteinsecretionmediatedviasec22bvesiclepathwayinlivercancer
AT koizumirei extendedsynaptotagmin1engagesinunconventionalproteinsecretionmediatedviasec22bvesiclepathwayinlivercancer
AT onomasaya extendedsynaptotagmin1engagesinunconventionalproteinsecretionmediatedviasec22bvesiclepathwayinlivercancer
AT tachibanatoshiaki extendedsynaptotagmin1engagesinunconventionalproteinsecretionmediatedviasec22bvesiclepathwayinlivercancer
AT yoshidaayano extendedsynaptotagmin1engagesinunconventionalproteinsecretionmediatedviasec22bvesiclepathwayinlivercancer
AT yoshidasaishu extendedsynaptotagmin1engagesinunconventionalproteinsecretionmediatedviasec22bvesiclepathwayinlivercancer
AT shimodamasayuki extendedsynaptotagmin1engagesinunconventionalproteinsecretionmediatedviasec22bvesiclepathwayinlivercancer
AT okamasahiro extendedsynaptotagmin1engagesinunconventionalproteinsecretionmediatedviasec22bvesiclepathwayinlivercancer
AT yonedayoshihiro extendedsynaptotagmin1engagesinunconventionalproteinsecretionmediatedviasec22bvesiclepathwayinlivercancer
AT yoshidakiyotsugu extendedsynaptotagmin1engagesinunconventionalproteinsecretionmediatedviasec22bvesiclepathwayinlivercancer